SCHEMBL8321303

SCHEMBL8321303

C/C(=N/O)c1cccc(Br)c1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ CYP2C19 P33261 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ C1S P09871 1/20 0.48
▸ PARP1 P09874 1/20 0.48
▸ MTOR P42345 3/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ GFER P55789 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7109724 1.00 NPC1 (0.54) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL17134067 1.00 NPC1 (0.54) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL28530493 0.89 CTSL (0.50) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL28127816 0.82 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL3725357 0.82 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
Bromobenzene SCHEMBL28232899 0.81 CYP2C19 (0.50) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL6815084 0.79 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL6815081 0.79 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL17008402 0.79 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL749086 0.78 C1S (0.56) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015178847-A1 PROCESS FOR THE PREPARATION OF CHIRAL AMINES BY ASYMMETRIC HYDROGENATION OF PROCHIRAL OXIMES SP PROCESS DEVELOPMENT AB (SE) 2015-11-26 — — WO disclosed
WO-2004071401-A2 HYDROXAMIC ACID DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS (HDCA) FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-26 — — WO disclosed
Send feedback